A jury at the US District Court for the District of Delaware has decided that medical technologies company C R Bard has not infringed a patent owned by W L Gore Associates, a company specialising in products derived from fluoropolymers.
The English High Court handed down a split decision on patentability in a dispute between Edwards Lifesciences and Boston Scientific over patents covering transcatheter heart valves.
“The Unified Patent Court without Britain is a far less potent idea,” says Nick McDonald, partner of Potter Clarkson.
The Federal Trade Commission has found after a public comment period that Abbott Laboratories’ $25 billion acquisition of St. Jude Medical would probably be anti-competitive.
The US Supreme Court has declined to review an appeal by Boston Scientific, which had been ordered to pay Maryland-based Mirowski Family Ventures $309 million in a patent dispute covering a defibrillator.
The US Supreme Court has “left more questions than it answered” in the Life Technologies v Promega ruling, which was handed down yesterday, according to lawyers.
Nano Dimension, a 3D printing electronics company, has revealed plans to launch a subsidiary focused on solutions for end-stage renal disease, a condition that leads to kidney failure.
IP management company CPA Global is looking to finalise a settlement agreement with medical diagnostic company Run Them Sweet (RTS) following allegations that CPA overcharged patent fees.
Medical device company Maquet Cardiovascular has filed an amended patent complaint against Saphena Medical and its former employee Albert Chin, adding claims of false advertising and correction of patent inventorship.
Allergan has completed its acquisition of LifeCell, a Canada-based regenerative medicine company, for $2.9 billion.